Paul Tudor Jones’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Paul Tudor Jones’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-52,500	Closed	-$1.12M	–	2914
2024 Q1	$1.12M	Buy	+52,500	New	+$628K	0.01%	1278

Paul Tudor Jones's FUSN Position: Q2 2024 in Review

Paul Tudor Jones sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 32,919 shares — an estimated $702K sold.

Paul Tudor Jones first reported a position in FUSN in Q2 2020 and held it in 2 quarters. The position peaked at $702K in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Paul Tudor Jones reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Paul Tudor Jones sold 32,919 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $702K.
Paul Tudor Jones first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q2 2020 and held it in 2 quarters.
Paul Tudor Jones's Fusion Pharmaceuticals Inc. Common Shares position peaked at $702K in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Tudor Investment Corp's 13F filing for Q2 2024, filed 14 Aug 2024.